Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

Affiliations

¹ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
² Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA.
³ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
⁴ Department of Research Bioinformatics, MedImmune LLC, Gaithersburg, MD, USA.
⁵ Autoimmunity, Transplantation, and Inflammation Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
⁶ Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.
⁷ Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA.
⁸ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. hergen.spits@amc.uva.nl.
⁹ Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA. alisonhumbles@gmail.com.

^# Contributed equally.

Published Erratum

Jochem H Bernink et al. Nat Immunol. 2020 Jan.

. 2020 Jan;21(1):101.

doi: 10.1038/s41590-019-0554-3.

¹ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
² Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA.
³ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
⁴ Department of Research Bioinformatics, MedImmune LLC, Gaithersburg, MD, USA.
⁵ Autoimmunity, Transplantation, and Inflammation Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
⁶ Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.
⁷ Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA.
⁸ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. hergen.spits@amc.uva.nl.
⁹ Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA. alisonhumbles@gmail.com.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies.
Bernink JH, Ohne Y, Teunissen MBM, Wang J, Wu J, Krabbendam L, Guntermann C, Volckmann R, Koster J, van Tol S, Ramirez I, Shrestha Y, de Rie MA, Spits H, Romero Ros X, Humbles AA. Bernink JH, et al. Nat Immunol. 2019 Aug;20(8):992-1003. doi: 10.1038/s41590-019-0423-0. Epub 2019 Jul 1. Nat Immunol. 2019. PMID: 31263279